Algorae Pharmaceuticals Ltd
Healthcare · AUD · ASX
Price
A$0.012
Cap
A$28.32M
Earnings
—
30d Trend
-14.3%
103% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 43×Macro 0.99 (−1%)=43
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Algorae Pharmaceuticals Ltd at 43/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 67/100. I classify this as a growth position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-14.3%
3 MONTHS
-29.4%
12 MONTHS
+100.0%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Momentum (67) and Technical (55) are the primary strengths. I note that quality is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 103%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.